Skip to main content
Fig. 5 | Journal of Biomedical Science

Fig. 5

From: Nintedanib antiangiogenic inhibitor effectiveness in delaying adenocarcinoma progression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP)

Fig. 5

VEGF immunoreactivity. a Quantification of epithelial VEGF immunoreactivity. b Quantification of stromal VEGF immunoreactivity. c Negative control. d T8 group. e TC12 group. f TN12 group. g TC16 group. h TN16 group. i TC22(8–12) group. j TN22(8–12) group. k TC22(12–16) group. l TN22(12–16) group. VEGF-positive staining is indicated by an asterisk in the stroma and arrow in the cytoplasm. Values expressed as media or maximum media values and compared between treated and its respective control group. **p < 0.01; ***p < 0.005. Ep = epithelium; St = stroma; L = lumen. Counter-stain: Harris Hematoxylin. 400x, bar = 100 μm

Back to article page

Journal of Biomedical Science

ISSN: 1423-0127